BioCardia, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
BioCardia, Inc. (BCDA) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 8.64 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-12
- BioCardia, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 8.38M shares, a 218.09% increase year-over-year.
- BioCardia, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 2.64M shares, a 609.17% increase year-over-year.
- BioCardia, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 371.60K shares, a 91.91% decline year-over-year.
- BioCardia, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 4.60M shares, a 13.58% increase year-over-year.
- BioCardia, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 8.43M shares, a 219.88% increase from fiscal 2024.
- BioCardia, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 2.64M shares, a 756.52% increase from fiscal 2023.
- BioCardia, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 307.67K shares, a 93.33% decline from fiscal 2022.
- BioCardia, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 4.61M shares, a 13.00% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 8.64M shares 10-Q · filed 2026-08-12 | |||||||
| 2026-03-31 | 8.38M shares 10-Q · filed 2026-05-15 | |||||||
| 2025-12-31 | 8.43M shares 10-K · filed 2026-03-24 | |||||||
| 2025-09-30 | 8.11M shares 10-Q · filed 2025-11-12 | |||||||
| 2025-06-30 | 3.32M shares 10-Q · filed 2026-08-12 | |||||||
| 2025-03-31 | 2.64M shares 10-Q · filed 2026-05-15 | |||||||
| 2024-12-31 | 2.64M shares 10-K · filed 2026-03-24 | |||||||
| 2024-09-30 | 2.62M shares 10-Q · filed 2025-11-12 | |||||||
| 2024-06-30 | 364.63K shares 10-Q/A · filed 2025-10-29 | |||||||
| 2024-03-31 | 371.60K shares 10-Q · filed 2025-05-14 | 5.57M shares 10-Q · filed 2024-05-14 | ||||||
| 2023-12-31 | 307.67K shares 10-K · filed 2025-03-26 | 4.62M shares 10-K · filed 2024-03-27 | ||||||
| 2023-09-30 | 324.58K shares 10-Q · filed 2024-11-13 | 4.87M shares 10-Q · filed 2023-11-08 | ||||||
| 2023-06-30 | 335.39K shares 10-Q · filed 2024-08-13 | 5.03M shares 10-Q · filed 2023-08-09 | ||||||
| 2023-03-31 | 4.60M shares 10-Q · filed 2024-05-14 | |||||||
| 2022-12-31 | 4.61M shares 10-K · filed 2024-03-27 | |||||||
| 2022-09-30 | 4.58M shares 10-Q · filed 2023-11-08 | |||||||
| 2022-06-30 | 4.49M shares 10-Q · filed 2023-08-09 | |||||||
| 2022-03-31 | 4.05M shares 10-Q · filed 2023-05-10 | |||||||
| 2021-12-31 | 4.08M shares 10-K · filed 2023-03-29 | |||||||
| 2021-09-30 | 4.11M shares 10-Q · filed 2022-11-09 | |||||||
| 2021-06-30 | 4.12M shares 10-Q · filed 2022-08-10 | |||||||
| 2021-03-31 | 3.52M shares 10-Q · filed 2022-05-11 | |||||||
| 2020-12-31 | 3.55M shares 10-K · filed 2022-03-29 | |||||||
| 2020-09-30 | 3.52M shares 10-Q · filed 2021-11-10 | |||||||
| 2020-06-30 | 3.57M shares 10-Q · filed 2021-08-12 | |||||||
| 2020-03-31 | 3.55M shares 10-Q · filed 2021-05-13 | 3.27M shares 10-Q · filed 2020-05-15 | ||||||
| 2019-12-31 | 3.29M shares 10-K · filed 2021-03-30 | |||||||
| 2019-09-30 | 3.31M shares 10-Q · filed 2020-11-10 | 3.35M shares 10-Q · filed 2019-11-19 | ||||||
| 2019-06-30 | 942.09K shares 10-Q · filed 2020-08-13 | |||||||
| 2019-03-31 | 932.33K shares 10-Q · filed 2020-05-15 | 8.39M shares 10-Q · filed 2019-05-15 | ||||||
| 2018-12-31 | 934.54K shares 10-K · filed 2020-04-09 | 8.41M shares 10-K · filed 2019-04-02 | ||||||
| 2018-09-30 | 646.27K shares 10-Q · filed 2019-11-19 | 5.82M shares 10-Q · filed 2018-11-08 | ||||||
| 2018-06-30 | 635.45K shares 10-Q · filed 2019-08-14 | 5.72M shares 10-Q · filed 2018-08-09 | ||||||
| 2018-03-31 | 3.88M shares 10-Q · filed 2019-05-15 | 5.70M shares 10-Q · filed 2018-05-10 | ||||||
| 2017-12-31 | 479.01K shares 10-K · filed 2020-04-09 | 4.31M shares 10-K · filed 2018-03-16 | ||||||
| 2017-09-30 | 4.24M shares 10-Q · filed 2018-11-08 | |||||||
| 2017-06-30 | 4.11M shares 10-Q · filed 2018-08-09 | 49.28M shares 10-Q · filed 2017-08-14 | ||||||
| 2017-03-31 | 3.88M shares 10-Q · filed 2018-05-10 | 46.54M shares 10-Q · filed 2017-05-11 | ||||||
| 2016-12-31 | 3.49M shares 10-K · filed 2019-04-02 | 41.90M shares 10-K · filed 2017-03-30 | ||||||
| 2016-09-30 | 18.64M shares 10-Q · filed 2017-11-09 | |||||||
| 2016-06-30 | 12.46M shares 10-Q · filed 2017-08-14 | |||||||
| 2016-03-31 | 12.60M shares 10-Q · filed 2017-05-11 | |||||||
| 2015-12-31 | 19.28M shares 10-K · filed 2018-03-16 | 231.40M shares 10-K · filed 2017-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |